Effects of adrenergic receptor activation and blockade on the systolic preejection period, heart rate, and arterial pressure in man

The Journal of Clinical Investigation
W S HarrisA M Weissler

Abstract

We have investigated the possibility that alterations in the duration of the systolic preejection period can be used to estimate adrenergic influences on the human left ventricle. The preejection period was determined from high speed, simultaneous recordings of the phonocardiogram, carotid pulse tracing, and electrocardiogram. The preejection period was shortened by isoproterenol, epinephrine, and moderate doses of norepinephrine-all of which activate beta adrenergic receptors-and by cedilanid-D. It was unaltered by changes in heart rate induced by atropine and right atrial electrical pacing. Beta adrenergic receptor blockade by propranolol abolished the shortening effects of the three catecholamines but did not inhibit that due to cedilanid-D. Vasoconstriction, both alpha adrenergic (epinephrine and norepinephrine after propranolol) and nonadrenergic (angiotensin), prolonged the preejection period. Most of the shortening of the preejection period by beta adrenergic receptor activating agents and cedilanid-D and all of the prolongation accompanying pharmacologic vasoconstriction occurred after the onset of the first heart sound, thereby excluding changes in electrical-mechanical delay as a major factor in the observed preejecti...Continue Reading

References

Aug 1, 1966·The American Journal of Cardiology·A Van Bogaert
Apr 1, 1966·The American Journal of Cardiology·W S HarrisA M Weissler
Jan 1, 1958·Cardiologia : bollettino della Società italiana di cardiologia·W RAABY K STARCHESKA
Jun 1, 1963·Circulation Research·A G WALLACES J SARNOFF
Jun 1, 1965·The Journal of Clinical Investigation·G GLICKE BRAUNWALD

❮ Previous
Next ❯

Citations

Feb 1, 1977·Journal of Clinical Pharmacology·A FieldmanM Sing Sum Chow
Jan 1, 1993·European Journal of Clinical Pharmacology·Q Li, G G Belz
Jan 1, 1982·European Journal of Applied Physiology and Occupational Physiology·R VrâncianuI Petersèn
Jan 1, 1983·European Journal of Clinical Pharmacology·K A MuhiddinP Turner
Jan 1, 1987·European Journal of Clinical Pharmacology·J H WilkensJ C Frölich
Jan 1, 1984·European Journal of Clinical Pharmacology·G G BelzB Schneider
Jul 19, 1977·European Journal of Clinical Pharmacology·E Q RolandP M Milliez
Sep 1, 1971·European Journal of Clinical Pharmacology·H J GilfrichR F Nicolescu
Mar 22, 1976·European Journal of Clinical Pharmacology·K O'MalleyJ McNay
Jan 1, 1974·European Journal of Clinical Pharmacology·F FreiU C Dubach
Jan 1, 1984·European Journal of Applied Physiology and Occupational Physiology·M MäntysaariT Peltonen
Jan 1, 1982·European Journal of Clinical Pharmacology·G G BelzD Palm
Jan 1, 1978·Circulation·T H Spodick
May 1, 1975·The American Journal of Cardiology·W FrishmanT Killip
Jan 1, 1987·Journal of Psychosomatic Research·M T AllenL A Grange
May 1, 1981·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J L EversC B Martin
May 1, 1981·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J L EversC B Martin
Jan 1, 1982·Pharmacology & Therapeutics·K O Haustein
Dec 1, 1989·Journal of the American College of Cardiology·M D McGoonA Olive
Apr 18, 1998·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·K C LightM T Allen
Mar 17, 1999·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·E S MezzacappaE S Katkin
Nov 1, 1983·Journal of the American College of Cardiology·Y NakamuraO H Bing
Jul 6, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carmilla M M LichtEco J C de Geus
Apr 15, 1971·The New England Journal of Medicine·G D FinlayL I Goldberg
Sep 20, 1973·The New England Journal of Medicine·S L FaulknerD G Shand
Feb 24, 1977·The New England Journal of Medicine·M EslerV DeQuattro
Sep 1, 1970·Archives of Environmental Health·H J MontoyeJ B Keller
Aug 1, 1978·British Journal of Clinical Pharmacology·D G Gibson
Jan 1, 1978·British Journal of Clinical Pharmacology·P G JacksonD E Jewitt
Jan 1, 1974·Acta Anaesthesiologica Scandinavica·J P Rasmussen, P Bech-Jansen
Jan 1, 1975·Acta Anaesthesiologica Scandinavica·J P RasmussenT Kann
Jan 1, 1975·Acta Anaesthesiologica Scandinavica·J P Rasmussen, B Sorensen
Jan 1, 1976·Acta Anaesthesiologica Scandinavica·A EngquistT Kann
Jan 1, 1977·Acta Anaesthesiologica Scandinavica·P Hommelgaard, S Eriksen
Jan 1, 1976·Australian and New Zealand Journal of Medicine·R C TaraziE L Bravo
Aug 1, 1992·Pacing and Clinical Electrophysiology : PACE·C P Lau
Mar 1, 1992·Journal of Veterinary Internal Medicine·C E Atkins, P S Snyder
Sep 1, 1971·British Heart Journal·J T DowlingC Urquhart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.